Skip to main content
Christopher Slapak, MD, Oncology, Indianapolis, IN

Christopher Alan Slapak MD


Physician

Join to View Full Profile
  • The Wishard Hospital Hematology Clinic1050 Wishard BlvdIndianapolis, IN 46202

  • Phone+1 317-630-7175

  • Fax+1 317-630-6310

Dr. Slapak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1984 - 1987
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1984

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1996 - 2025
  • IL State Medical License
    IL State Medical License 1986 - 1987
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33
    PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33January 14th, 2021
  • Vor Announces FDA Clearance of IND Application for VOR33
    Vor Announces FDA Clearance of IND Application for VOR33January 14th, 2021
  • Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute
    Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer InstituteNovember 11th, 2020
  • Join now to see all

Grant Support

  • Anthracycline Efflux In Multiresistant Leukemia CellsNational Cancer Institute1991–1995
  • Anthracycline Efflux In Multiresistant Leukemia CellsNational Cancer Institute1991
  • Early Doxorubicin Resistant Mammalian Leukemia CellsNational Cancer Institute1989–1990

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: